Sep 2, 2015

The Health Science Authority (HSA), Singapore’s medical device market regulator, will begin publishing field safety corrective action (FSCA) information on its website to boost public awareness of risk and safety issues involving devices legally sold in the country.

The new FSCA policy will apply both to new incidents and retroactively to those occurring between January and August 2015. Field safety notice information published by the HSA will include device name, company name and contact details for local representatives.

Only field safety notices filed by local representatives such as Singapore Authorized Representatives with the HSA will be made publically available, according to an analysis of the new policy by Emergo consultants in Singapore.

The HSA's new field safety notice publication policy brings Singapore regulations in line with those of other major medical device regulatory agencies that have implemented similar processes for public access to FSCA data.

Author

  • Stewart Eisenhart

Related

Faster Market Pathway in Effect for Higher-Risk Devices in Singapore

Singapore’s medical device market regulator, the Health Sciences Authority (HSA), has set up expedited registration routes for higher-risk Class C and D devices in the country beginning January 1, 2013 in order to improve public access to new medical technologies. Similar expedited registration routes were launched by the HSA in 2012 for lower-risk Class A and B devices.

Read more

Singapore HSA Proposes New Medical Device and IVD Grouping Criteria

The Health Sciences Authority (HSA), Singapore’s medical device market regulator, has issued new draft guidance expanding grouping criteria for medical and in vitro diagnostic devices submitted for registration.

Read more

Have questions on what Emergo can do for you?

CONTACT US